We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/6/2018 20:10 | Not really, jpuff. A lot of us TILS holders became so only because were unfortunate enough to have been in RGT - especially genises. | asmodeus | |
11/6/2018 16:35 | For any Rgt holders tap news in the epic and also search on google colostrinin images You will find a new supplier for USA and Europe | genises | |
07/6/2018 17:03 | What a massive disappointment this has become over the past year. Feel totally let down by the abysmal share price performance. | jpuff | |
23/5/2018 14:25 | Hmm now what's going on? -31% | jpuff | |
27/4/2018 14:58 | No trades at all here no matter how low the price is. We either need some news to get it noticed or else I fear it will fade still further into obscurity and the abyss. | jpuff | |
27/4/2018 08:03 | See what I mean, lol | stenick | |
27/4/2018 07:12 | Lol Asmodeus, predictive text. Daicaprice, I’m expecting lots of news here over the next couple of months as they have said. Oral foralumab trial news,nasal foralumab IND applied for,Milciclib trial with soranafib (Bayer drug) starting, and application for marketing Licence for Milciclib. All these they have said they are aiming for. I am monitoring the FDA and EMA sites as they list all new applications for drugs. But as you probably know already that AIM companies do not always go well as expected. They have raised a lot of money recently, from £1.50p to 80p, and of course the tax rebates that will amount to about £3mill, so l hope no more fund raising will occur. Your Call. Good luck all | stenick | |
26/4/2018 21:31 | I have a few here from £1.52, I have written them off but am tempted to get myself down to av £1. Any thoughts on my sanity and should I do so? DC | daicaprice | |
26/4/2018 21:13 | Yes - I used to hate PT - but it cured my Asthma :) | asmodeus | |
26/4/2018 07:25 | Hi Stav We did and I think we do have a chance of a return. 25p. To 240p to 80p and lots of ups and down in between is a traders dream surely. Nothing has changed they still have some potentially really good products, loads of money, and news to come, all with less than 150mill shares in issue. The crash and Beauforts going bust has not helped the share price I suspect. I’m still hopeful here as I like what I hear about Milciclib and the thought of using a nasal spray to combat auto immune dieseas’s is appealing to me let alone big pharma. I’ve recouped some losses and hope for a bit more here. Anyway nice to hear from you Stav hope your ok. | stenick | |
26/4/2018 07:20 | Yes- still here, and still hopeful of getting something back. Percy taught me one important lesson (without intending to), and that was never to put too many eggs in one basket! So I am seriously diversified, and mainly in investment trusts, and this has produced adequate income and some capital gains post-Regen. How are you getting on, Stav? | asmodeus | |
25/4/2018 19:18 | ASMO Are you still here? | stav5001 | |
25/4/2018 19:17 | Hi Stenick I thought we had a chance of getting something back here but its not looking good. | stav5001 | |
19/4/2018 08:15 | No comment either about the collapse in share price from 240p to 80p at a time when Beauforts put out a BUY recommendation at 200p+ .Mind you we are all aware of the circumstances surrounding Beauforts demise and we are looking to the FSCS to help out there. The whole saga stinks eh! | jpuff | |
19/4/2018 07:51 | Pity existing loyal shareholders are now being diluted out of existence. | jpuff | |
16/4/2018 14:43 | Nice RNS. I like that they mention Alzheimer’s. A lot going on. Shame about share price but I think that will change. | stenick | |
09/4/2018 10:40 | Good RNS, am amazed with the results and safety profile of Milciclib it’s not on the market yet.Perhaps they are in collaboration with Bayer to see how their trial goes with sorafenib. | stenick | |
09/4/2018 07:53 | The mm’s must have accumulated a lot of shares by now. | stenick | |
06/4/2018 21:21 | And down again on yesterday's wonderful news :( | jpuff | |
05/4/2018 15:25 | lol. Yes new broker, good news, no delisting :). Leopoldo hopefully will organise a strategy that gets the marketing licence for Milciclib and starts the trial with the Bayer drug,and starts the Foralumab trial.Or at least give us an update. Things do take so long. | stenick | |
05/4/2018 08:15 | At least we now have a new broker now. Also looks like the guy who bought the one share yesterday has panicked and sold it first thing this morning! ;) | jpuff | |
04/4/2018 12:40 | 1,000,000 would be a nicer buy Stenick :) but a good announcement today nonetheless. | jpuff |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions